Clinical pharmacogenomics and concept of personalized medicine
The term 'personalized medicine' (PM) was coined in the late 1990s, but was not introduced to general US public until about a decade later, through Genomics and Personalized Medicine Act. According to this act, PM is defined as any clinical practice model that utilizes genomic and family h...
Main Author: | Babić Nikolina |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Medical Biochemists of Serbia, Belgrade
2012-01-01
|
Series: | Journal of Medical Biochemistry |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2012/1452-82581204281B.pdf |
Similar Items
-
Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
by: Alireza Tafazoli, et al.
Published: (2021-03-01) -
Updating the landscape of direct-to-consumer pharmacogenomic testing
by: Filipski KK, et al.
Published: (2017-08-01) -
Pharmacogenomics and Personalized Medicine
by: Erika Cecchin, et al.
Published: (2020-06-01) -
Cannabis Pharmacogenomics: A Path to Personalized Medicine
by: Mariana Babayeva, et al.
Published: (2023-04-01) -
Personalized medicine in breast cancer: pharmacogenomics approaches
by: Jeibouei S, et al.
Published: (2019-05-01)